Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158


Promoting adherence to treatment for latent TB infection through mobile phone text messaging: study protocol for a pilot randomized controlled trial.

Oren E, Bell ML, Garcia F, Perez-Velez C, Gerald LB.

Pilot Feasibility Stud. 2017 Mar 13;3:15. doi: 10.1186/s40814-017-0128-9. eCollection 2017.


Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia.

Bain EE, Shafner L, Walling DP, Othman AA, Chuang-Stein C, Hinkle J, Hanina A.

JMIR Mhealth Uhealth. 2017 Feb 21;5(2):e18. doi: 10.2196/mhealth.7030.


Cocaine Enhances DC to T-cell HIV-1 Transmission by Activating DC-SIGN/LARG/LSP1 Complex and Facilitating Infectious Synapse Formation.

Prasad A, Kulkarni R, Jiang S, Groopman JE.

Sci Rep. 2017 Jan 17;7:40648. doi: 10.1038/srep40648.


Depression at Treatment Initiation Predicts HIV Antiretroviral Adherence in Uganda.

Wagner GJ, Slaughter M, Ghosh-Dastidar B.

J Int Assoc Provid AIDS Care. 2017 Jan/Feb;16(1):91-97. doi: 10.1177/2325957416677121. Epub 2016 Nov 30.


Might ART Adherence Estimates Be Improved by Combining Biomarker and Self-Report Data?

Rhead R, Masimirembwa C, Cooke G, Takaruza A, Nyamukapa C, Mutsimhi C, Gregson S.

PLoS One. 2016 Dec 14;11(12):e0167852. doi: 10.1371/journal.pone.0167852. eCollection 2016.


Rates and Predictors of Non-Adherence to Antiretroviral Therapy among HIV-Positive Individuals in Kenya: Results from the Second Kenya AIDS Indicator Survey, 2012.

Mukui IN, Ng'ang'a L, Williamson J, Wamicwe JN, Vakil S, Katana A, Kim AA.

PLoS One. 2016 Dec 1;11(12):e0167465. doi: 10.1371/journal.pone.0167465. eCollection 2016.


International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK.

[No authors listed]

J Int AIDS Soc. 2016 Oct 23;19(8(Suppl 7)):21487. doi: 10.7448/IAS.19.8.21487. eCollection 2016. No abstract available.


A Comparison of Adherence Timeframes Using Missed Dose Items and Their Associations with Viral Load in Routine Clinical Care: Is Longer Better?

Crane HM, Nance RM, Delaney JA, Fredericksen RJ, Church A, Simoni JM, Harrington RD, Dhanireddy S, Safren SA, McCaul ME, Lober WB, Crane PK, Wilson IB, Mugavero MJ, Kitahata MM.

AIDS Behav. 2017 Feb;21(2):470-480. doi: 10.1007/s10461-016-1566-8.


A Dyadic Behavioral Intervention to Optimize Same Sex Male Couples' Engagement Across the HIV Care Continuum: Development of and Protocol for an Innovative Couples-based Approach (Partner Steps).

Bazzi AR, Fergus KB, Stephenson R, Finneran CA, Coffey-Esquivel J, Hidalgo MA, Hoehnle S, Sullivan PS, Garofalo R, Mimiaga MJ.

JMIR Res Protoc. 2016 Aug 25;5(3):e168. doi: 10.2196/resprot.6271.


Anxiety sensitivity and hazardous drinking among persons living with HIV/AIDS: An examination of the role of emotion dysregulation.

Paulus DJ, Jardin C, Bakhshaie J, Sharp C, Woods SP, Lemaire C, Leonard A, Neighbors C, Brandt CP, Zvolensky MJ.

Addict Behav. 2016 Dec;63:141-8. doi: 10.1016/j.addbeh.2016.07.013. Epub 2016 Jul 21.


Factors associated with 10 years of continuous viral load suppression on HAART.

Bello KJ, Mesner O, O'Bryan TA, Won SH, Lalani T, Ganesan A, Agan BK, Okulicz JF.

BMC Infect Dis. 2016 Jul 22;16:351. doi: 10.1186/s12879-016-1677-x.


Contingency Management Interventions for HIV, Tuberculosis, and Hepatitis Control Among Individuals With Substance Use Disorders: A Systematized Review.

Herrmann ES, Matusiewicz AK, Stitzer ML, Higgins ST, Sigmon SC, Heil SH.

J Subst Abuse Treat. 2017 Jan;72:117-125. doi: 10.1016/j.jsat.2016.06.009. Epub 2016 Jun 24.


HIV Infection Care and Viral Suppression Among People Who Inject Drugs, 28 U.S. Jurisdictions, 2012-2013.

Karch DL, Gray KM, Shi J, Hall HI.

Open AIDS J. 2016 Jun 15;10:127-35. doi: 10.2174/1874613601610010127. eCollection 2016.


Cocaine Enhances HIV-1 Transcription in Macrophages by Inducing p38 MAPK Phosphorylation.

Swepson C, Ranjan A, Balasubramaniam M, Pandhare J, Dash C.

Front Microbiol. 2016 Jun 9;7:823. doi: 10.3389/fmicb.2016.00823. eCollection 2016.


Duration of Viral Suppression and Risk of Rebound Viremia with First-Line Antiretroviral Therapy in Rural Uganda.

Musinguzi N, Mocello RA, Boum Y 2nd, Hunt PW, Martin JN, Haberer JE, Bangsberg DR, Siedner MJ.

AIDS Behav. 2017 Jun;21(6):1735-1740. doi: 10.1007/s10461-016-1447-1.


Alcohol Interactive Toxicity Beliefs and ART Non-adherence Among HIV-Infected Current Drinkers in Mbarara, Uganda.

Fatch R, Emenyonu NI, Muyindike W, Kekibiina A, Woolf-King S, Hahn JA.

AIDS Behav. 2016 May 19. [Epub ahead of print]


Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney Disease.

Weiss JJ, Konstantinidis I, Boueilh A, Fierer DS, Gardenier D, Barber MG, Kang T, Kress A, Ericson K, Lira MC, Yostos MP, Bogner HR, Wisnivesky JP, Wyatt CM.

J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):403-410.


Lamivudine Concentration in Hair and Prediction of Virologic Failure and Drug Resistance among HIV Patients Receiving Free ART in China.

Yan J, Liu J, Su B, Pan X, Wang Z, Wu J, Zhang J, Ruan Y, Hsi J, Liao L, Shao Y, Xing H.

PLoS One. 2016 Apr 27;11(4):e0154421. doi: 10.1371/journal.pone.0154421. eCollection 2016.


A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse.

Kuchinad KE, Hutton HE, Monroe AK, Anderson G, Moore RD, Chander G.

BMC Res Notes. 2016 Apr 22;9:229. doi: 10.1186/s13104-016-2032-4.


Substance Use and Adherence Among People Living with HIV/AIDS Receiving cART in Latin America.

De Boni RB, Shepherd BE, Grinsztejn B, Cesar C, Cortés C, Padgett D, Gotuzzo E, Belaunzarán-Zamudio PF, Rebeiro PF, Duda SN, McGowan CC.

AIDS Behav. 2016 Nov;20(11):2692-2699.


Supplemental Content

Support Center